HSL Mobile App Ongoing NFO
ICICI Prudential Pharma Healthcare and Diagnostics Fund
Investment Objective
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and other allied companies.
Investment Strategy
The fund aims to make investors participate in the core, non-discretionary healthcare sector by investing in Pharmaceuticals, Hospitals, Diagnostics, Preventives, Health Insurance and other allied sectors. India is one of the fastest growing healthcare markets in the world and increasing awareness, improving government expenditure and private investments makes this scheme a long term pick for investors.
| Scheme Details | |
| Scheme Name | ICICI Prudential Pharma Healthcare and Diagnostics (PHD) Fund ( View Report ) |
| Fund Manager | Mr. Ihab M Dalwai |
| NFO Period | 25 Jun 18 to 09 Jul 18 |
| Fund Type | An open-ended equity scheme following Pharma, Healthcare, Diagnostics and other allied themes |
| Minimum Investment | Rs 5,000 (and in multiple of Re 1 thereafter) |
| Available Options | Growth and Dividend |
| Entry/Exit Load | Nil/1% up to 18 months and nil thereafter |
| Benchmark | S&P BSE Healthcare Index |
| Face Value | Rs 10 |
| Riskometer | High |
